|
|
|
Insider
Information: |
Vitullo Nicole |
Relationship: |
10% Owner |
City: |
Richmond |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
3,769,432 |
|
Indirect Shares
|
2,643,947 |
|
|
Direct
Value |
$48,749,193 |
|
|
Indirect Value
|
$8,566,768 |
|
|
Total
Shares |
6,413,379 |
|
|
Total
Value |
$57,315,961 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-29.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-12 |
8,000 |
Premium* |
|
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2005-07-28 |
668 |
2005-07-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-04 |
3,333 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2006-05-09 |
100,355 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-28 |
5,142 |
2008-04-24 |
56,718 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
3,019 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
Director |
2020-01-28 |
0 |
2020-01-28 |
0 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2023-06-15 |
36,918 |
2019-03-21 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-07 |
1,973,389 |
2014-05-01 |
0 |
Premium* |
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
6,442 |
2021-03-16 |
0 |
Premium* |
|
Colucid Pharmaceuticals, Inc. |
CLCD |
10% Owner |
2016-09-09 |
0 |
|
0 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
10% Owner |
2016-03-08 |
1,743,854 |
2016-03-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
164 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONXX |
Onyx Pharmaceuticals Inc |
Director |
|
2005-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
668 |
668 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,889,086 |
32,297 |
|
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
3,203,594 |
33,968 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-13 |
4 |
A |
$0.00 |
$0 |
I/I |
5,842 |
5,842 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(571,000) |
2,285,789 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-18 |
4 |
S |
$13.03 |
$84,161 |
I/I |
(6,459) |
25,838 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2006-10-30 |
4 |
A |
$0.00 |
$0 |
I/I |
5,713,622 |
60,584 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
10,675 |
10,675 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(634,000) |
2,535,626 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(581,176) |
1,954,450 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-12-21 |
4 |
S |
$13.52 |
$87,326 |
I/I |
(6,459) |
19,379 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-12-21 |
4 |
D |
$0.00 |
$0 |
I/I |
(571,000) |
1,714,789 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-12-21 |
4 |
A |
$0.00 |
$0 |
I/I |
9,614 |
15,456 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2007-09-12 |
4 |
A |
$0.00 |
$0 |
I/I |
53,376 |
55,238 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2008-02-20 |
4 |
A |
$5.34 |
$14,999,996 |
I/I |
2,808,988 |
90,369 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-04-24 |
4 |
A |
$0.00 |
$0 |
I/I |
1,480 |
56,718 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,277 |
5,142 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-08 |
4 |
B |
$4.47 |
$1,110,397 |
I/I |
248,411 |
4,173 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-09 |
4 |
B |
$4.93 |
$1,192,518 |
I/I |
241,890 |
8,237 |
1.5 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2009-02-18 |
4 |
B |
$7.13 |
$19,826,206 |
I/I |
2,780,674 |
46,634 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-11 |
4 |
B |
$7.60 |
$792,680 |
I/I |
104,300 |
20,887 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-12 |
4 |
B |
$8.00 |
$3,200,000 |
I/I |
400,000 |
27,595 |
1.5 |
- |
|
164 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|